Company page

Ascelia Pharma Ab

Ascelia Pharma AB is a public company listed on the Swedish market under the ticker ACE. The company has a market capitalization of approximately 41.7 million USD. Ascelia Pharma focuses on developing innovative treatments for cancer patients, particularly in the field of rare diseases.

profileACE:OMXSTOAI content: aiUpdated June 24, 2026/company/ascelia-pharma-ab/c-py6f9fea
Ascelia Pharma Ab logo
Ticker
ACE:OMXSTO
Asset type
Stock
Market cap
$41.7M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OMXSTO
Currency
SEK